从少阴病论治颈椎病的理论探讨与炎症机制研究进展
A Theoretical Discussion on the Treatment of Cervical Spondylosis Based on the Theory of Shao Yin Syndrome and Recent Advances in Research on Inflammatory Mechanisms
摘要: 颈椎病以风寒痹阻型最为常见,传统八纲与脏腑辨证在精准辨治方面存在一定局限。六经辨证源自《伤寒论》,其中少阴病“阳虚寒凝”病机与风寒痹阻型颈椎病的证候特征高度契合。麻黄附子细辛汤作为少阴病代表方剂,具有温经发表、散寒止痛之功效。现代药理学研究证实,其单味药及复方可通过多途径调控肿瘤坏死因子-α (TNF-α)、白细胞介素-6 (IL-6)、白细胞介素-1β (IL-1β)等炎症因子,进而影响颈椎病疼痛的发生与维持。本文从少阴病理论出发,系统探讨麻黄附子细辛汤加味治疗风寒痹阻型颈椎病的中医理论依据,并结合炎症因子介导的疼痛机制,综述中医药调控该病的现代研究进展,以期为六经辨证指导颈椎病治疗提供理论支撑。
Abstract: Among cervical spondylosis cases, the “wind-cold obstruction” pattern is the most common; however, the traditional Eight Principles and Zang-Fu pattern differentiation methods have certain limitations in terms of precise diagnosis and treatment. The Six Channel pattern differentiation originates from the “Treatise on Cold Damage”; specifically, the pathogenic mechanism of “yang deficiency with cold congealing” in Shaoyin disease aligns closely with the clinical manifestations of the “wind-cold obstruction” pattern in cervical spondylosis. As a representative formula for Shaoyin disease, Ma Huang Fu Zi Xi Xin Decoction possesses the therapeutic effects of warming the meridians, expelling pathogens, dispelling cold and alleviating pain. Modern pharmacological research has confirmed that its individual herbs and the compound formula can regulate inflammatory factors such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) via multiple pathways, thereby influencing the onset and maintenance of pain in cervical spondylosis. Based on the theory of Shaoyin disease, this paper systematically explores the theoretical basis in Traditional Chinese Medicine for the use of Ma Huang Fu Zi Xi Xin Decoction with modifications in the treatment of cervical spondylosis of the wind-cold obstruction type. By integrating the pain mechanisms mediated by inflammatory factors, it reviews modern research progress on the regulation of this disease through Traditional Chinese Medicine, with the aim of providing theoretical support for the treatment of cervical spondylosis guided by the Six Channel Differentiation.
文章引用:向剑锋. 从少阴病论治颈椎病的理论探讨与炎症机制研究进展[J]. 中医学, 2026, 15(6): 202-207. https://doi.org/10.12677/tcm.2026.156332

参考文献

[1] 梁建义, 尹拥军, 黄发义. 中西医结合治疗神经根型颈椎病的研究进展[J]. 医药前沿, 2025, 15(28): 39-42.
[2] 肖蕾, 潘洁, 高育龙, 等. 基于“肌骨调衡”学术思想行滞动针疗法治疗风寒痹阻型神经根型颈椎病[J]. 颈腰痛杂志, 2024, 45(1): 145-149.
[3] 李剑锋. 浅析《伤寒杂病论》辨经、辨证治疗颈椎病[J]. 中国民间疗法, 2020, 28(1): 4-5.
[4] 葛飞, 罗亚敏, 周冉冉, 等. 麻黄细辛附子汤治“太少两感”痛证辨析[J]. 中国中医急症, 2022, 31(2): 355-357.
[5] 孟俊谷. 温针灸联合羌活胜湿汤对风寒痹阻型椎动脉型颈椎病的临床疗效及对血清炎性因子含量的影响[J]. 内蒙古中医药, 2025, 44(2): 100-102.
[6] 李浩, 林良武, 汪阳. 麻黄附子细辛汤加味治疗寒湿型腰椎间盘突出症的疗效观察[J]. 蚌埠医学院学报, 2021, 46(3): 368-371.
[7] 陈寅清, 韩世盛, 王怡. 从《伤寒论》少阴篇讨论阳虚阴盛证辨治规律[J]. 浙江中医药大学学报, 2024, 48(3): 324-327+331.
[8] 杨镇旭, 李俊海, 马玉峰, 等. 基于六经辨证运用葛根汤化裁治疗神经根型颈椎病的回顾性研究[J]. 中国中医骨伤科杂志, 2022, 30(4): 54-57.
[9] 洪健峰, 吕静, 陈其剑. 麻黄附子细辛汤治疗少阴寒化证经验撷英[J]. 四川中医, 2023, 41(10): 3-6.
[10] 闫朝光, 孙瑞华. 麻黄附子甘草汤之“无证”辨[J]. 江苏中医药, 2018, 50(8): 66-67.
[11] 闫安平. 浅析麻黄附子细辛汤及其临床运用[J]. 基层中医药, 2023, 2(8): 20-22.
[12] 唐诚, 刘芳. 国医大师刘祖贻临证运用麻黄附子细辛汤经验[J]. 湖南中医杂志, 2024, 40(5): 29-32.
[13] 张昺磊, 张志明, 宋忠阳, 等. 麻黄附子细辛汤及其加减方的临床应用研究进展[J]. 世界中西医结合杂志, 2022, 17(12): 2525-2528+2534.
[14] 高鹏辉, 梁文华. 麻黄附子细辛汤临床应用研究进展[J]. 中国中医药现代远程教育, 2022, 20(17): 206-208.
[15] 李记泉, 孟翔宇, 韩知渊, 等. 从经气运行解析麻黄附子细辛汤证的机制与应用[J]. 中华中医药杂志, 2021, 36(1): 200-203.
[16] Yeshna, Singh, M., Monika,, Kumar, A., Garg, V. and Jhawat, V. (2025) Pathophysiology and Emerging Therapeutic Strategies for Cervical Spondylosis: The Role of Pro-Inflammatory Mediators, Kinase Inhibitors, and Organogel Based Drug Delivery Systems. International Immunopharmacology, 151, Article 114350. [Google Scholar] [CrossRef] [PubMed]
[17] 庄见雄, 莫宜璋, 邓棕元, 等. 退行性颈椎病相关神经病理性疼痛的机制与多模式治疗: 现状与进展[J]. 中南大学学报(医学版), 2024(11): 1840-1848.
[18] 张昺磊, 张志明, 朱鹏, 等. 麻黄附子细辛汤的化学成分及药理作用研究进展[J]. 现代中西医结合杂志, 2023, 32(9): 1304-1308.
[19] 卓小玉, 陈晶, 田明, 等. 麻黄的化学成分与药理作用研究进展[J]. 中医药信息, 2021, 38(2): 80-83.
[20] 荣宝山, 黄凯丽, 袁琳嫣, 等. 乌头类药材化学成分和药理作用研究进展[J]. 中国药事, 2021, 35(8): 932-947.
[21] 张瑜, 张红, 李宁, 等. 细辛化学成分和药理作用的研究进展及其质量标志物的预测分析[J]. 天然产物研究与开发, 2023, 35(10): 1794-1807.
[22] Zhang, H.J., Liao, H.Y., Bai, D.Y., et al. (2021) MAPK/ERK Signaling Pathway: A Potential Target for the Treatment of Intervertebral Disc Degeneration. Biomedicine & Pharmacotherapy, 143, Article 112170. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, Y., Cheng, H., Wang, T., Zhang, K., Zhang, Y. and Kang, X. (2023) Oxidative Stress in Intervertebral Disc Degeneration: Molecular Mechanisms, Pathogenesis and Treatment. Cell Proliferation, 56, e13448. [Google Scholar] [CrossRef] [PubMed]
[24] Zhang, X., Zhang, Z., Zou, X., Wang, Y., Qi, J., Han, S., et al. (2023) Unraveling the Mechanisms of Intervertebral Disc Degeneration: An Exploration of the P38 MAPK Signaling Pathway. Frontiers in Cell and Developmental Biology, 11, Article 1324561. [Google Scholar] [CrossRef] [PubMed]
[25] 师燕飞. 麻黄附子细辛汤临床应用研究进展[J]. 中医药临床杂志, 2020, 32(11): 2195-2197.
[26] 胡芷涵, 张鼎, 胡跃强. 中药附子药理学及毒理学的研究进展[J]. 湖南中医杂志, 2024, 40(12): 201-205.
[27] 张恒文, 余万桂. 益气温阳中药治疗膝骨关节炎疗效及对炎性细胞因子、NO水平的影响[J]. 长江大学学报(自科版), 2017(12): 1-3+99.